glp-1 receptor agonists and cancer risk in adults with obesity Frontiers The effect of GLP-1R agonists
Description
Importantly, this increase in insulin happens only when glucose levels rise (i.e., when the body needs insulin)
Authorities are monitoring how these drugs are being used across different care settings, including telehealth platforms and direct-to-consumer models
They act by binding to GLP-1 receptors, which are widely distributed in the body, including cardiomyocytes and blood vessels
The older AOMs represent less than 3 percent of weight-loss medication costs
De Schryver AM, Andriesse GI, Samsom M, Smout AJ, Gooszen HG, Akkermans LM
Ongoing and future trials need to assess and clarify further the cardiovascular and overall safety profile of GLP-1 receptor agonists
